A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/502 (2006.01) A61K 31/517 (2006.01)
Patent
CA 2256227
A pharmaceutical composition for treating a psychiatric condition or disorder selected from anxiety disorders such as panic disorder, posttraumatic stress disorder and phobias, psychotic episodes of anxiety, anxiety associated with psychosis, psychotic mood disorders such as severe major depressive disorder and mood disorders associated with psychotic disorders such as acute mania or depression associated with bipolar disorder, schizophrenia, behavioral manifestations of mental retardation, conduct disorder or autistic disorder, dementias such as dementias of the Alzheimer's type, and dyskinesias such as drug-induced and neurodegeneration based dyskinesias in a mammal, including a human, comprising administering to said mammal a pharmaceutically effective amount of a compound of the formula: Image or a pharmaceutically acceptable acid addition salt thereof, wherein preferably X and Y, together with the phenyl to which they are attached, form benzoxazolonyl or oxindole optionally substituted by chloro, fluoro or phenyl; Ar is benzoisothiazolyl or naphthyl; and n is 1; together with a pharmaceutically acceptable diluent or carrier.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Method of treating psychiatric conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating psychiatric conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating psychiatric conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1532203